Business Standard

NCLAT stays NCLT order approving Dhanuka Lab's resolution plan for Orchid

The CoC had selected the proposal of Dhanuka Laboratories and gone ahead with the voting even as Accord Life Spec approached the NCLT against CoC's decision

Orchid Pharma
Premium

Orchid Pharma

Gireesh Babu Chennai
The National Company Law Appellate Tribunal (NCLAT) has stayed the National Company Law Tribunal's (NCLT) order, which approved the resolution plan of Dhanuka Laboratories Ltd for the revival of Orchid Pharma Ltd, after a petition was filed by Chennai-based Accord Life Spec Pvt Ltd. The Bench has ordered that a notice be issued to the pharma company and others, and posted the case for hearing on August 28, 2019.

The NCLAT Bench, comprising Chairperson Justice S J Mukhopadhaya, Member (Judicial) Justice AIS Cheema and Member (Technical) Kanthi Narahari, said that the stay on the NCLT order would continue during the pendency

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in